Market Survey on Airway Management Devices Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Airway Management Devices Market including Laryngeal Masks, Tracheostomy Tubes, Endotravheal Tubes, EndoBronhial Tubes, Nasal Airway Tubes, and Oral Airway Tubes. Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
The airway management devices marketis expected to be worth US$ 1.6 billion in 2023 and expected to record a 3.6% CAGR from 2023 to 2033, reaching around US$ 2.2 billion.
Report Attribute
Details
Airway Management Devices Market Value (2023)
US$ 1.6 billion
Airway Management Devices Market Anticipated Value (2033)
US$ 2.2 billion
Airway Management Devices Market Growth Rate (2023 to 2033)
3.6% CAGR
Airway management devices are used to keep or restore a patient's ventilation. These devices also include assessing, planning, and implementing various medical methods to treat patients with respiratory failures or acute blockages. Aside from that, it shields the lungs from harm and allows patients to exchange gas. Supraglottic airway devices (SADs), tracheal intubation, trans tracheal access, and airway clearance are a few of the most often utilised airway management devices for keeping the upper airway open and providing unobstructed ventilation
Patients may require airway care for a variety of reasons, ranging from simple choking to complicated airway obstruction. For airway management, several specific clinical signs must be evaluated. Among them are respiratory failure, poor consciousness, rapid changes in mental status, aggressive choking, and penetrating injuries.
Depending on the circumstances, hospitals may employ a variety of airway management procedures. Basic airway care employs non-invasive techniques that do not need the use of specialist medical devices. Techniques to remove foreign bodies from the airway include chest compressions, abdominal thrusts, and back strikes. These factors are expected to drive the growth of the airway management devices market in the approaching years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Demand for Emergency and Intensive Care will drive the market growth
Patients with viral, chronic, or cardiac illnesses frequently experience airway issues, necessitating rapid medical attention. The demand for airway management devices is increasing as a result of a variety of circumstances, including traffic accident victims and people suffering from other traumatic injuries. The global demand for airway management devices is increasing due to critically ill and trauma patients being admitted to emergency rooms and intensive care units. As a result of the pandemic's rapid spread, admissions to emergency rooms and intensive care units have skyrocketed worldwide. These factors are expected to drive future growth in the airway management devices market.
2017 to 2022 Airway Management Devices Market Outlook in Comparison to 2023 to 2033 Growth Forecast
The Airway management devices market was valued at US$ 1.5 billion in 2022 and is estimated to increase at a 3.2% CAGR during the forecast period. Absolute dollar growth in the global market is US$ 668.5 million.
The increase in funds allocated by the federal government to promote the use of airway-management medical devices has also had an impact on the expansion of the airway-management devices market share. The revenue generated by the airway management devices market is additionally boosted by growing healthcare spending, improvements in healthcare infrastructure, and an increase in the need for long-term care delivery. Furthermore, the respiratory system alters geometrically, physiologically, and immunologically as we age. Chest wall and thoracic spine deformities are examples of structural anomalies that influence overall respiratory system compliance, resulting in airway irritation.
The increased incidence of respiratory infections and anaesthesia consumption as a result of more surgeries are expected to fuel the demand for airway management devices and positively impact the global airway management devices market growth. Moreover, as a result of technical advancements, key competitors are forging strategic alliances to boost the airway management device market. This feature is projected to generate several chances for key players to boost the airway management devices market.
Find your sweet spots for generating winning opportunities in this market.
Comparative Analysis of Adjacent Markets
This section presents a comparative analysis of three closely related markets: the airway management devices market, the airway disease treatment market, and the airway management market. Examining these analogous industries unveils deeper insights that can inform the development of unique and differentiating strategies for achieving sustainable growth and capitalizing on opportunities within the airway management devices market.
Airway Management Devices Market:
Differentiating Aspects
Airway Management Devices Market
Anticipated CAGR (2023 to 2033)
3.6%
Market Valuation (2023)
US$ 1.6 billion
Growth Factors
Increasing prevalence of chronic respiratory disease among the global population is expected to increase the growth of the global airway management devices market.
Future Opportunities
Medical equipment resuscitators, tracheostomy tubes, laryngoscope blades, and resuscitators endotracheal tubes are widely used in healthcare facilities.
Market Trends
Rising frequency of respiratory disorders.
Airway Disease Treatment Market:
Differentiating Aspects
Airway Disease Treatment Market
Anticipated CAGR (2023 to 2033)
5.4%
Market Valuation (2023)
US$ 2.2 billion
Growth Factors
Rising prevalence of respiratory diseases such as asthma, cystic fibrosis and COPD across the world, the demand for airway disease treatment is expected to skyrocket to a considerable extent.
Future Opportunities
Introduction of advanced imaging technologies such as digital radiography and computed radiography as they render high-quality digital images.
Market Trends
Digital imaging systems have witnessed a low adoption rate as these are more expensive than analogue imaging systems.
Airway Management Market:
Differentiating Aspects
Airway Management Market
Anticipated CAGR (2023 to 2033)
6%
Market Valuation (2023)
US$ 2.01 billion
Growth Factors
Increasing demand for emergency and intensive care.
Future Opportunities
Growing demand for single-use airway management.
Market Trends
Increase in patients’ admissions in emergency and intensive care units.
Advancement in airway management technology for the management of paediatric airways is expected to boost the airway management device market growth over the forecast period. Children have different anatomy and physiology structures as compared to adults. Also, the diagnosis and treatment of paediatric airways is difficult. Technological advancements can provide ease in paediatric airway diagnosis and treatment.
Airway management is the priority in any critical patient. Hypoxia can cause irreversible brain injury. So, in this type of state, airway management is the first priority before proceeding to any other treatment. This creates opportunities in the market for new device innovation and market growth. Currently, manufacturers of airway management devices are consistently making changes in their product categories and technologies in order to enhance the capabilities of the devices. This is expected to enhance their sale and increase the market share in the long term.
The global airway management devices market is expected to record a CAGR of 3.2% through the forecast period from 2022 to 2028.
Which Factors are Restraining the Demand for Airway Management Devices Market?
Complications and limitations associated with airway management due to intubation and other factors are expected to hamper the global airway management devices market growth.
Endotracheal intubation is a commonly performed airway management procedure in hospitals, but it also comprises risks and complications. Endotracheal intubation involves the risk of injuries such as dental injury, nasoseptal injury, laryngotracheal stenosis, and tracheoesophageal fistulas, among others. Dental trauma is also associated with laryngeal mask airway and oropharyngeal airway devices. Moreover, limitations & contraindications associated with laryngeal mask airway devices include morbid obesity, non-fasted patients, and airway problems at the glottic level, thoracic trauma, and the necessity for high inspiratory pressure in the presence of pulmonary compliance and COPD.
Product recalls of airways management devices are negatively affecting the growth of the global airways management device market. Due to the product recalls, the company losses their brand image and thus, these recalls negatively impact the revenue of the company.
The rise in Respiratory Disease Prevalence to Drive Airway Management Devices Market Growth
The rise in chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is fueling demand for airway management devices. Chronic obstructive pulmonary disorders, such as bronchitis and emphysema, as well as lung cancer and other respiratory tract neoplasms, have a substantial impact on airways and lung structures. The prevalence of respiratory disorders is rising as a result of environmental and lifestyle factors such as air pollution, smoking, sedentary lifestyles, and stress.
Demand for airway management devices is being driven by increased patients suffering from such diseases, and the quick introduction and availability of portable, cost-contained, and simple-to-use airway equipment for the treatment of such ailments. Airway stenting and airway clearing systems are the two distinct therapies that make use of airway management devices.
According to the World Health Organization (WHO), over 65 million individuals had chronic obstructive pulmonary disease (COPD), and 3 million died from it, making it the third-leading cause of mortality in the world. More than 80% of these fatalities occurred in poor and middle-income nations.
Asthma affects about 262 million individuals worldwide each year, making it the most common chronic paediatric condition, affecting 14% of all children. Tuberculosis (TB) killed around 1.4 million people in 2022, making it the most prevalent deadly infectious illness. Lung cancer is the deadliest type of cancer, killing 1.6 million people each year.
The chronic respiratory disease kills 4 million individuals prematurely worldwide. At least 2 billion individuals are exposed to harmful smoke indoors, 1 billion to outdoor pollutants in the air, and 1 billion to cigarette smoke.
The Elderly Population's High Susceptibility to Chronic Respiratory Diseases will drive demand for Airway Management Devices
The rise in world population can be ascribed to an increase in people's life expectancy over the last decade. A person's immune system diminishes with age. Consequently, the growing older population increases the risk of developing numerous diseases. The amount of adults above the age of 60 is likely to increase in the future years. Additionally, chronic respiratory illnesses have become common as the elderly population has grown. This is expected to drive demand for airway management devices over the projected period.
An increase in the prevalence of chronic respiratory diseases (CRD) in adults is estimated to boost the demand for airway management devices. According to Centres for Disease Control and Prevention (CDC) data, the prevalence of COPD, emphysema, or chronic bronchitis in adults increased in 2023. As a result, individuals suffering from emphysema or chronic bronchitis have raised global demand for airway management equipment.
Increased demand for Single-use Airway Management Devices is likely to create numerous opportunities.
Airway management devices are among the medical devices utilized in a variety of applications within the healthcare business. Single-use medical equipment are resuscitators, tracheostomy tubes, laryngoscope blades, and resuscitators endotracheal tubes. These are widely used in healthcare facilities to provide value-based care services and treat critically ill patients with highly contagious illnesses such as H1N1 influenza or severe pneumonia. Furthermore, single-use devices have several advantages over reusable ones because they are already cleaned and ready to use, safeguarding patients from medical-care-related infections. In the past, it extended the use of single-use airway management devices throughout healthcare facilities to meet infection-control regulations.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Airway Management Devices Market Trends
One of the primary factors driving the market is the rising frequency of respiratory disorders. Furthermore, the use of anaesthesia is increasing due to rising procedures. This, together with the numerous advantages of airway management systems, such as high efficiency in airway clearance, the maintenance of proper ventilation and patient safety during operating procedures, are also contributing to market expansion. Furthermore, a surge in the emergency treatment of extended illness and protracted treatment associated with lung illnesses in children and adults is fuelling demand for airway management devices. Furthermore, the introduction of new procedures for preoperative airway examination is bolstering market growth.
For example, Preoperative Endoscopic Airway Evaluation (PEAE) is a procedure that identifies, predicts, and facilitates an efficient management strategy, which includes the use of sophisticated equipment such as supraglottic airway. These airway devices facilitate tracheal implantation, which improves patient safety, and are then used in a variety of therapeutic applications.
A Glimpse of Country-wise Insights
Country
United States
CAGR (2017 to 2022)
3.2%
Valuation (2023 to 2033)
US$ 66.5 million
Country
China
CAGR (2017 to 2022)
5.0%
Valuation (2023 to 2033)
US$ 107.0 million
Country
Japan
CAGR (2017 to 2022)
3.4%
Valuation (2023 to 2033)
US$ 135.5 million
Country
India
CAGR (2017 to 2022)
3.7%
Valuation (2023 to 2033)
US$ 46.2 million
North America is likely to dominate the market for airway management devices
Because of the prevalence of asthma and chronic obstructive pulmonary disease, as well as the expanding older population, North America dominates the market for airway management devices. According to the United States Census Bureau, more than 50 million Americans aged 65 and older are at high risk of acquiring chronic diseases that necessitate immediate ventilation as of 2022.
The United States and Canada are two significant countries in North America where such medical gadgets have been widely embraced. The primary causes of the growth in the demand for airway management devices in North America include rising pollution levels and an increase in respiratory disorders, even in newborn care.
Due to advantageous reimbursement policies, an increase in healthcare R&D spending, and a growth in the incidence of chronic diseases such as COPD, the United States market is expected to expand significantly throughout the forecast period. COPD affects 12.7 to 14.7 million persons in the United States, according to the WHO data. The presence of the medical industry in North America will aid in the expansion of the region's airway management device market share.
What Makes the United States Large Market for Airway management devices market?
The United States is estimated to account for 92.7% of the North American airway management devices market in 2022 owing to the high acceptance of technologically advanced products, increase in the prevalence of chronic respiratory diseases, and favourable reimbursement regulations for airway management devices in the region.
Why is Germany Considered a Lucrative in the Airway management devices market?
Germany accounted for 18.3% market share in Europe in 2022 in value terms. Industrial advancement, the geriatric population and the rise in research and development spending are the factor boosting the demand for airway management devices market in Germany.
The risk associated with airways related problems increases with age. The growing geriatric population is considered an important factor bolstering the airway management devices market. According to the available WHO data from 2018, lung disease fatalities in Germany were 48,209, accounting for 6.27% of all deaths. Germany ranks 112 in the world with an age-adjusted death rate of 20.04 per 100,000 of population.
How will the Airway management devices market grow Across China?
Recently demand for airway management devices market in China owing to an increase in the outsourcing of the manufacturing airway management devices led to account over 20% market share in 2022 in the Asia Pacific region.
Government and administrative assortments in China are adopting different cost-control measures to decrease the healthcare burden. This move from a volume- to a value-based framework is fuelled by different measures taken by healthcare providers, medical device companies, governments and insurance payers that incorporate result-based estimating, price control and competitive tendering, profit, and risk sharing. Furthermore, the presence of untapped opportunities in this region, as well as the rising burden of the ageing populations, who are more susceptible to chronic respiratory disorders, rapid industrialization, and an increase in disposable income are the significant factors expected to propel the airway management devices market during the forecasted period. Moreover, increasing awareness and disease prevalence along with a strong foothold of leading industry players generated abundant growth potential in this region.
Demand for Endobronchial Tubes continue gaining traction by product?
Endobronchial tubes accounted for a significant share of over 43.0% in 2021. The growing demand for these products is due to the benefits they provide. The most important benefit is improved patient safety, which encourages patients and anesthesiologists to choose these devices.
The introduction of a single or double-lumen endobronchial tube with a camera offers a promising solution in thoracoscopic lung surgery, as well as being advantageous in robotic surgery. During installation and single lung ventilation, a single/double-lumen endobronchial tube with a camera offers continuous real-time monitoring. This factor can further propel the airway management devices market.
Which Usage segment is leading the market share?
By usage type, single-use/ disposable accounted for 83.1% of the market share in 2022 due to its safety purpose with infection prevention and reduced chance of cross-infection. Airway management devices are directly used in the human airway lumen for instant relief.
So for such delivery, patient safety and infection prevention are at most priority that is easily achieved by single-use devices. Disposable devices avoid cross-infection risk, are easy to insert and are proven to be a safe method for airway management as compared to tubes. These factors are gaining traction for the market growth at present and in the forecast period.
Which End User will hold the most of the market share?
By end user, hospitals dominated the market with a market share of 47.8% in 2022 owing to increasing surgical procedures including the use of airway management equipment for ventilation, oxygenation, and anaesthetic administration. Additionally, airway management devices are easily handled in hospitals. Also, the more walk-in patient is seen in hospitals and growing government efforts targeted at enhancing safety and preventing adverse occurrences are significant contributors to the segment's growth in the forecast period.
Competitive Landscape
The global market for airway management devices is highly concentrated, with a limited amount of large-scale vendors controlling the majority of market share. Key participants in the global market include:
Medtronic Plc
Teleflex Incorporated
Ambu A/S
Smith’s Group plc.
Intersurgical Ltd.
Cook Medical Inc.
SunMed
Vyaire Medical Inc
VBM Medizintechnik GmbH
Karl Storz SE & Co. KG
Cook Gas LLC
Flexicare (Group) Limited
BVLM Pty Ltd
Boston Medical Products Inc. (BESS GROUP)
Salter Labs
Scope of Report
Attribute
Details
Market Size Value in 2023
US$ 1.6 billion
Market Size Value in End of Forecast (2033)
US$ 2.2 billion
Market Analysis
US$ billion for Value
Key Region Covered
North America
Latin America
Europe
Asia Pacific
The Middle East & Africa
Key Segments
By Product Type
By Usage Type
By End User
By Region
Key Companies Profiled
Medtronic Plc
Teleflex Incorporated
Ambu A/S
Smith’s Group plc.
Intersurgical Ltd.
Cook Medical Inc.
SunMed
Vyaire Medical Inc
VBM Medizintechnik GmbH
Karl Storz SE & Co. KG
Cook Gas LLC
Flexicare (Group) Limited
BVLM Pty Ltd
Boston Medical Products Inc. (BESS GROUP)
Salter Labs
Report Coverage
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Airway Management Devices Market Key Segments
By Product Type:
Laryngeal Masks
Tracheostomy Tubes
Endotravheal Tubes
EndoBronhial Tubes
Nasal Airway Tubes
Oral Airway Tubes.
By Usage Type:
Single Use/ Disposable
Reusable
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Region:
North America
Latin America
Europe
Asia Pacific
The Middle East & Africa
Frequently Asked Questions
What is the market size in 2023?
The market is valued at US$ 1.6 billion in 2023.
What is the CAGR from 2023 to 2033?
The market is projected to reach 3.6% CAGR.
What will the market size be in 2033?
The market will grow by US$ 2.2 billion in 2033.
What is the expected market value in China?
China's market is expected to be worth US$ 135.5 million by 2033.
Who are the key market players?
Medtronic Plc, Teleflex Incorporated, and Ambu A/S are key players.
Table of Content
1. Executive Summary | Airway Management Devices Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Laryngeal Masks
5.3.2. Tracheostomy Tubes
5.3.3. Endotravheal Tubes
5.3.4. EndoBronhial Tubes
5.3.5. Nasal Airway Tubes
5.3.6. Oral Airway Tubes
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Usage Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Usage Type, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Usage Type, 2023 to 2033
6.3.1. Single Use/ Disposable
6.3.2. Resuable
6.4. Y-o-Y Growth Trend Analysis By Usage Type, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Usage Type, 2023 to 2033
7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Specialty Clinics
7.4. Y-o-Y Growth Trend Analysis By End User , 2017 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Usage Type
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Usage Type
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Usage Type
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Usage Type
10.3.4. By End User
10.4. Key Takeaways
11. Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United kingdom
11.2.1.3. France
11.2.1.4. Italy
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. Rest of Europe
11.2.2. By Product Type
11.2.3. By Usage Type
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Usage Type
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. India
12.2.1.3. Australia
12.2.1.4. Japan
12.2.1.5. Rest of Asia Pacific
12.2.2. By Product Type
12.2.3. By Usage Type
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Usage Type
12.3.4. By End User
12.4. Key Takeaways
13. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Saudi Arabi
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product Type
13.2.3. By Usage Type
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Usage Type
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product Type
14.1.2.2. By Usage Type
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product Type
14.2.2.2. By Usage Type
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product Type
14.3.2.2. By Usage Type
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product Type
14.4.2.2. By Usage Type
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product Type
14.5.2.2. By Usage Type
14.5.2.3. By End User
14.6. United kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product Type
14.6.2.2. By Usage Type
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product Type
14.7.2.2. By Usage Type
14.7.2.3. By End User
14.8. Italy
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product Type
14.8.2.2. By Usage Type
14.8.2.3. By End User
14.9. Spain
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product Type
14.9.2.2. By Usage Type
14.9.2.3. By End User
14.10. Russia
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product Type
14.10.2.2. By Usage Type
14.10.2.3. By End User
14.11. China
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product Type
14.11.2.2. By Usage Type
14.11.2.3. By End User
14.12. India
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product Type
14.12.2.2. By Usage Type
14.12.2.3. By End User
14.13. Australia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product Type
14.13.2.2. By Usage Type
14.13.2.3. By End User
14.14. Japan
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product Type
14.14.2.2. By Usage Type
14.14.2.3. By End User
14.15. Saudi Arabia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Product Type
14.15.2.2. By Usage Type
14.15.2.3. By End User
14.16. South Africa
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Product Type
14.16.2.2. By Usage Type
14.16.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Usage Type
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Medtronic Plc
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Teleflex Incorporated
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Ambu A/S
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Smiths Group plc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Intersurgical Ltd.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Cook Medical Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. SunMed
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Vyaire Medical Inc
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. VBM Medizintechnik GmbH
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Karl Storz SE & Co. KG
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.11. Cook Gas LLC
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.12. Flexicare (Group) Limited
16.1.12.1. Overview
16.1.12.2. Product Portfolio
16.1.12.3. Profitability by Market Segments
16.1.12.4. Sales Footprint
16.1.12.5. Strategy Overview
16.1.12.5.1. Marketing Strategy
16.1.13. BVLM Pty Ltd
16.1.13.1. Overview
16.1.13.2. Product Portfolio
16.1.13.3. Profitability by Market Segments
16.1.13.4. Sales Footprint
16.1.13.5. Strategy Overview
16.1.13.5.1. Marketing Strategy
16.1.14. Boston Medical Products Inc.
16.1.14.1. Overview
16.1.14.2. Product Portfolio
16.1.14.3. Profitability by Market Segments
16.1.14.4. Sales Footprint
16.1.14.5. Strategy Overview
16.1.14.5.1. Marketing Strategy
17. Assumptions & Acronyms Used18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Value (US$ Million) Forecast by Region, 2017 to 2033
Table 2: Global Value (US$ Million) Forecast by Product Type, 2017 to 2033
Table 3: Global Value (US$ Million) Forecast by Usage Type, 2017 to 2033
Table 4: Global Value (US$ Million) Forecast by End User , 2017 to 2033
Table 5: North America Value (US$ Million) Forecast by Country, 2017 to 2033
Table 6: North America Value (US$ Million) Forecast by Product Type, 2017 to 2033
Table 7: North America Value (US$ Million) Forecast by Usage Type, 2017 to 2033
Table 8: North America Value (US$ Million) Forecast by End User , 2017 to 2033
Table 9: Latin America Value (US$ Million) Forecast by Country, 2017 to 2033
Table 10: Latin America Value (US$ Million) Forecast by Product Type, 2017 to 2033
Table 11: Latin America Value (US$ Million) Forecast by Usage Type, 2017 to 2033
Table 12: Latin America Value (US$ Million) Forecast by End User , 2017 to 2033
Table 13: Europe Value (US$ Million) Forecast by Country, 2017 to 2033
Table 14: Europe Value (US$ Million) Forecast by Product Type, 2017 to 2033
Table 15: Europe Value (US$ Million) Forecast by Usage Type, 2017 to 2033
Table 16: Europe Value (US$ Million) Forecast by End User , 2017 to 2033
Table 17: Asia Pacific Value (US$ Million) Forecast by Country, 2017 to 2033
Table 18: Asia Pacific Value (US$ Million) Forecast by Product Type, 2017 to 2033
Table 19: Asia Pacific Value (US$ Million) Forecast by Usage Type, 2017 to 2033
Table 20: Asia Pacific Value (US$ Million) Forecast by End User , 2017 to 2033
Table 21: MEA Value (US$ Million) Forecast by Country, 2017 to 2033
Table 22: MEA Value (US$ Million) Forecast by Product Type, 2017 to 2033
Table 23: MEA Value (US$ Million) Forecast by Usage Type, 2017 to 2033
Table 24: MEA Value (US$ Million) Forecast by End User , 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Value (US$ Million) by Product Type, 2023 to 2033
Figure 2: Global Value (US$ Million) by Usage Type, 2023 to 2033
Figure 3: Global Value (US$ Million) by End User , 2023 to 2033
Figure 4: Global Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Value (US$ Million) Analysis by Region, 2017 to 2033
Figure 6: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Value (US$ Million) Analysis by Product Type, 2017 to 2033
Figure 9: Global Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 10: Global Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 11: Global Value (US$ Million) Analysis by Usage Type, 2017 to 2033
Figure 12: Global Value Share (%) and BPS Analysis by Usage Type, 2023 to 2033
Figure 13: Global Y-o-Y Growth (%) Projections by Usage Type, 2023 to 2033
Figure 14: Global Value (US$ Million) Analysis by End User , 2017 to 2033
Figure 15: Global Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 16: Global Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 17: Global Attractiveness by Product Type, 2023 to 2033
Figure 18: Global Attractiveness by Usage Type, 2023 to 2033
Figure 19: Global Attractiveness by End User , 2023 to 2033
Figure 20: Global Attractiveness by Region, 2023 to 2033
Figure 21: North America Value (US$ Million) by Product Type, 2023 to 2033
Figure 22: North America Value (US$ Million) by Usage Type, 2023 to 2033
Figure 23: North America Value (US$ Million) by End User , 2023 to 2033
Figure 24: North America Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 26: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Value (US$ Million) Analysis by Product Type, 2017 to 2033
Figure 29: North America Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 30: North America Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 31: North America Value (US$ Million) Analysis by Usage Type, 2017 to 2033
Figure 32: North America Value Share (%) and BPS Analysis by Usage Type, 2023 to 2033
Figure 33: North America Y-o-Y Growth (%) Projections by Usage Type, 2023 to 2033
Figure 34: North America Value (US$ Million) Analysis by End User , 2017 to 2033
Figure 35: North America Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 36: North America Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 37: North America Attractiveness by Product Type, 2023 to 2033
Figure 38: North America Attractiveness by Usage Type, 2023 to 2033
Figure 39: North America Attractiveness by End User , 2023 to 2033
Figure 40: North America Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Value (US$ Million) by Product Type, 2023 to 2033
Figure 42: Latin America Value (US$ Million) by Usage Type, 2023 to 2033
Figure 43: Latin America Value (US$ Million) by End User , 2023 to 2033
Figure 44: Latin America Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 46: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Value (US$ Million) Analysis by Product Type, 2017 to 2033
Figure 49: Latin America Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 50: Latin America Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 51: Latin America Value (US$ Million) Analysis by Usage Type, 2017 to 2033
Figure 52: Latin America Value Share (%) and BPS Analysis by Usage Type, 2023 to 2033
Figure 53: Latin America Y-o-Y Growth (%) Projections by Usage Type, 2023 to 2033
Figure 54: Latin America Value (US$ Million) Analysis by End User , 2017 to 2033
Figure 55: Latin America Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 56: Latin America Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 57: Latin America Attractiveness by Product Type, 2023 to 2033
Figure 58: Latin America Attractiveness by Usage Type, 2023 to 2033
Figure 59: Latin America Attractiveness by End User , 2023 to 2033
Figure 60: Latin America Attractiveness by Country, 2023 to 2033
Figure 61: Europe Value (US$ Million) by Product Type, 2023 to 2033
Figure 62: Europe Value (US$ Million) by Usage Type, 2023 to 2033
Figure 63: Europe Value (US$ Million) by End User , 2023 to 2033
Figure 64: Europe Value (US$ Million) by Country, 2023 to 2033
Figure 65: Europe Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 66: Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Europe Value (US$ Million) Analysis by Product Type, 2017 to 2033
Figure 69: Europe Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 70: Europe Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 71: Europe Value (US$ Million) Analysis by Usage Type, 2017 to 2033
Figure 72: Europe Value Share (%) and BPS Analysis by Usage Type, 2023 to 2033
Figure 73: Europe Y-o-Y Growth (%) Projections by Usage Type, 2023 to 2033
Figure 74: Europe Value (US$ Million) Analysis by End User , 2017 to 2033
Figure 75: Europe Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 76: Europe Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 77: Europe Attractiveness by Product Type, 2023 to 2033
Figure 78: Europe Attractiveness by Usage Type, 2023 to 2033
Figure 79: Europe Attractiveness by End User , 2023 to 2033
Figure 80: Europe Attractiveness by Country, 2023 to 2033
Figure 81: Asia Pacific Value (US$ Million) by Product Type, 2023 to 2033
Figure 82: Asia Pacific Value (US$ Million) by Usage Type, 2023 to 2033
Figure 83: Asia Pacific Value (US$ Million) by End User , 2023 to 2033
Figure 84: Asia Pacific Value (US$ Million) by Country, 2023 to 2033
Figure 85: Asia Pacific Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 86: Asia Pacific Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Asia Pacific Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Asia Pacific Value (US$ Million) Analysis by Product Type, 2017 to 2033
Figure 89: Asia Pacific Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 90: Asia Pacific Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 91: Asia Pacific Value (US$ Million) Analysis by Usage Type, 2017 to 2033
Figure 92: Asia Pacific Value Share (%) and BPS Analysis by Usage Type, 2023 to 2033
Figure 93: Asia Pacific Y-o-Y Growth (%) Projections by Usage Type, 2023 to 2033
Figure 94: Asia Pacific Value (US$ Million) Analysis by End User , 2017 to 2033
Figure 95: Asia Pacific Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 96: Asia Pacific Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 97: Asia Pacific Attractiveness by Product Type, 2023 to 2033
Figure 98: Asia Pacific Attractiveness by Usage Type, 2023 to 2033
Figure 99: Asia Pacific Attractiveness by End User , 2023 to 2033
Figure 100: Asia Pacific Attractiveness by Country, 2023 to 2033
Figure 101: MEA Value (US$ Million) by Product Type, 2023 to 2033
Figure 102: MEA Value (US$ Million) by Usage Type, 2023 to 2033
Figure 103: MEA Value (US$ Million) by End User , 2023 to 2033
Figure 104: MEA Value (US$ Million) by Country, 2023 to 2033
Figure 105: MEA Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 106: MEA Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: MEA Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: MEA Value (US$ Million) Analysis by Product Type, 2017 to 2033
Figure 109: MEA Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 110: MEA Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 111: MEA Value (US$ Million) Analysis by Usage Type, 2017 to 2033
Figure 112: MEA Value Share (%) and BPS Analysis by Usage Type, 2023 to 2033
Figure 113: MEA Y-o-Y Growth (%) Projections by Usage Type, 2023 to 2033
Figure 114: MEA Value (US$ Million) Analysis by End User , 2017 to 2033
Figure 115: MEA Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 116: MEA Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 117: MEA Attractiveness by Product Type, 2023 to 2033
Figure 118: MEA Attractiveness by Usage Type, 2023 to 2033
Figure 119: MEA Attractiveness by End User , 2023 to 2033
Figure 120: MEA Attractiveness by Country, 2023 to 2033
